文献速递胸部肿瘤

密西西比三角洲队列中因年龄过小或过大而不适合肺癌筛查者偶然检出的肺癌

Incidentally Detected Lung Cancer in Persons Too Young or Too Old for Lung Cancer Screening in a Mississippi Delta Cohort.
PubMed 文献 · J Thorac Oncol · 2023-11-19

在密西西比三角洲队列中,比较低剂量CT筛查人群与肺结节项目(LNP)中年龄过小(35至<50岁)和过大(>80岁)者的肺癌风险。2年累积肺癌诊断风险在筛查组为3.0%,年轻LNP组0.79%,老年LNP组6.5%。老年LNP风险高于Lung-RADS 3但低于4,年轻LNP与Lung-RADS 1-2相似;LNP对年龄不合格者略有获益。

要点

  • 年轻LNP组2年累积肺癌风险0.79%,与Lung-RADS 1(aHR=0.88)和2(aHR=1.0)相似。
  • 老年LNP组2年累积风险6.5%,高于Lung-RADS 3(aHR=2.34)但低于4(aHR=0.28)。
  • LNP对年龄过小或过大者略有获益,但分期和生存均差于筛查组。

核心结论

  • LNP对年龄过小或过大而不适合筛查者略有获益,但三组间临床特征和结局差异提示肺癌生物学特征不同。

研究设计与样本

  • 前瞻性观察性研究,比较2015至2022年低剂量CT筛查参与者(50-80岁)与LNP中年龄35至<50岁(年轻)和>80岁(老年)参与者的2年累积肺癌诊断风险、肺癌特征和总生存。

主要发现

  • 肺癌诊断例数分别为LDCT组329例(3.43%)、年轻LNP组39例(1.07%)、老年LNP组172例(6.87%)。
  • 2年累积发病率分别为LDCT组3.0%(95%CI 2.6%-3.4%)、年轻LNP组0.79%(95%CI 0.54%-1.1%)、老年LNP组6.5%(95%CI 5.5%-7.6%)。
  • 年轻LNP组肺癌诊断风险与Lung-RADS 1(aHR=0.88,95%CI 0.50-1.56)和Lung-RADS 2(aHR=1.0,95%CI 0.58-1.72)相似。
  • 老年LNP组风险高于Lung-RADS 3(aHR=2.34,95%CI 1.50-3.65),但低于Lung-RADS 4(aHR=0.28,95%CI 0.22-0.35)。
  • I或II期肺癌比例在LDCT组为62.92%,年轻LNP组33.33%(p=0.0003),老年LNP组48.26%(p=0.0004);IV期诊断比例分别为16.72%、41.03%、29.65%。

关键数值与推荐

  • 5年总生存率分别为LDCT组57%(95%CI 48-67)、年轻LNP组55%(95%CI 39-79)、老年LNP组24%(95%CI 15-40)(log-rank p<0.0001)。
  • 排除任何癌症病史者后结果相似。

临床怎么用

  • LNP对年龄过小或过大而不适合筛查者略有获益。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Lung cancer risk in screening age-ineligible persons with incidentally detected lung nodules is poorly characterized. We evaluated lung cancer risk in two age-ineligible Lung Nodule Program (LNP) cohorts. METHODS: Prospective observational study comparing 2-year cumulative lung cancer diagnosis risk, lung cancer characteristics, and overall survival between low-dose computed tomography (LDCT) screening participants aged 50 to 80 years and LNP participants aged 35 to younger than 50 years (young) and older than 80 years (elderly). RESULTS: From 2015 to 2022, lung cancer was diagnosed in 329 (3.43%), 39 (1.07%), and 172 (6.87%) LDCT, young, and elderly LNP patients, respectively. The 2-year cumulative incidence was 3.0% (95% confidence intervals [CI]: 2.6%-3.4%) versus 0.79% (CI: 0.54%-1.1%) versus 6.5% (CI: 5.5%-7.6%), respectively, but lung cancer diagnosis risk was similar between young LNP and Lung CT Screening Reporting and Data System (Lung-RADS) 1 (adjusted hazard ratio [aHR] = 0.88 [CI: 0.50-1.56]) and Lung-RADS 2 (aHR = 1.0 [0.58-1.72]). Elderly LNP risk was greater than Lung-RADS 3 (aHR = 2.34 [CI: 1.50-3.65]), but less than 4 (aHR = 0.28 [CI: 0.22-0.35]). Lung cancer was stage I or II in 62.92% of LDCT versus 33.33% of young (p = 0.0003) and 48.26% of elderly (p = 0.0004) LNP cohorts; 16.72%, 41.03%, and 29.65%, respectively, were diagnosed at stage IV. The aggregate 5-year overall survival rates were 57% (CI: 48-67), 55% (CI: 39-79), and 24% (CI: 15-40) (log-rank p < 0.0001). Results were similar after excluding persons with any history of cancer. CONCLUSIONS: LNP modestly benefited persons too young or old for screening. Differences in clinical characteristics and outcomes suggest differences in biological characteristics of lung cancer in these three patient cohorts.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Liao W, Fehnel C, Goss J, et al. Incidentally Detected Lung Cancer in Persons Too Young or Too Old for Lung Cancer Screening in a Mississippi Delta Cohort. J Thorac Oncol. 2023. PMID: 37984678. doi:10.1016/j.jtho.2023.11.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。